Management of submacular hemorrhage with intravitreal injection of tissue plasminogen activator and expansile gas

Retina

Volumn 27, Issue 3, 2007, Pages 321-328

  Chen, Christine Y ^a,b   Hooper, Claire ^a   Chiu, Daniel ^a,b   Chamberlain, Matthew ^a   Karia, Niral ^c   Heriot, Wilson J ^d  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ROYAL VICTORIAN EYE AND EAR HOSPITAL   (Australia)

^c SOUTHEND HOSPITAL   (United Kingdom)

^d CABRINI INSTITUTE   (Australia)

Author keywords

Age related macular degeneration; Submacular hemorrhage; Tissue plasminogen activator

Indexed keywords

ALTEPLASE; OCTAFLUOROPROPANE; SULFUR HEXAFLUORIDE;

ADULT; AGED; ARTICLE; CLINICAL EXAMINATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; RETINA ANGIOGRAPHY; RETINA DETACHMENT; RETINA MACULA HEMORRHAGE; RETROSPECTIVE STUDY; TREATMENT OUTCOME; VISUAL ACUITY; VITREOUS HEMORRHAGE;

ADULT; AGED; AGED, 80 AND OVER; DRUG THERAPY, COMBINATION; FEMALE; FIBRINOLYTIC AGENTS; FLUOROCARBONS; HUMANS; INJECTIONS; INTRAOPERATIVE COMPLICATIONS; MALE; MIDDLE AGED; RETINAL HEMORRHAGE; RETROSPECTIVE STUDIES; SULFUR HEXAFLUORIDE; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME; VISUAL ACUITY; VITREOUS BODY;

EID: 33947134938     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.iae.0000237586.48231.75     Document Type: Article

References (40)

1. Hochman M, Seery C, Zarbin M. Pathophysiology and management of subretinal haemorrahge. Surv Ophthalmol 1997;42:195-213.
2. Bennett S, Folk J, Blodi C, Klugman M. Factors prognostic of visual outcome in patients with subretinal hemorrhage. Am J Ophthalmol 1990;109:33-37.
3. Avery RL, Fekrat S, Hawkins BS, Bressler NM. Natural history of subfoveal subretinal hemorrhage in age-related macular degeneration. Retina 1996;16:183-189.
4. Chen WL, Liu JH, Lee FL. Natural course of submacular hemorrhage. Chung Hua i Hsueh Tsa Chih Chinese Med J 1999;62:268-277.
5. Submacular Surgery Trials Research. Surgery for subfoveal choroidal neovascularization in age-related macular degeneration: Ophthalmic findings: SST report no. 11. Ophthalmology 2004;111:1967.
6. Glatt H, Machemer R. Experimental subretinal hemorrhage in rabbits. Am J Ophthalmol 1982;94:762-773.
7. Lewis H, Resnick SC, Flannery JG, Straatsma BR. Tissue plasminogen activator treatment of experimental subretinal hemorrhage. Am J Ophthalmol 1991;111:197-204.
8. Toth C, Morse L, Hjelmeland L, Landers M. Fibrin directs early retinal damage after experimental subretinal hemorrhage. Arch Ophthalmol 1991;109:723-729.
9. Coll GE, Sparrow JR, Marinovic A, Chang S. Effect of intravitreal tissue plasminogen activator on experimental subretinal hemorrhage. Retina 1995;15:319-326.
10. Boone DE, Boldt HC, Ross RD, Folk JC, Kimura AE. The use of intravitreal tissue plasminogen activator in the treatment of experimental subretinal hemorrhage in the pig model. Retina 1996;16:518-524.
11. Sawa MM, Ober MDM, Spaide RFM. Autofluorescence and retinal pigment epithelial atrophy after subretinal hemorrhage. Retina 2006;26:119-120.
12. Johnson MW, Olsen KR, Hernandez E. Tissue plasminogen activator treatment of experimental subretinal hemorrhage. Retina 1991;11:250-258.
13. Hassan AS, Johnson MW, Schneiderman TE, et al. Management of submacular hemorrhage with intravitreous tissue plasminogen activator injection and pneumatic displacement. Ophthalmology. 1999;106:1900-1907.
14. Hesse L, Schmidt J, Kroll P. Management of acute submacular hemorrhage using recombinant tissue plasminogen activator and gas. Graefes Arch Clin Exp Ophthalmol 1999;237:273-277.
15. Krepler K, Kruger A, Tittl M, Stur M, Wedrich A. Intravitreal injection of tissue plasminogen activator and gas in subretinal hemorrhage caused by age-related macular degeneration. Retina 2000;20:251-256.
16. Hattenbach LO, Klais C, Koch FH, Gumbel HO. Intravitreous injection of tissue plasminogen activator and gas in the treatment of submacular hemorrhage under various conditions. Ophthalmology 2001;108:1485-1492.
17. Ibanez HE, Williams DF, Thomas MA, et al. Surgical management of submacular hemorrhage. A series of 47 consecutive cases. Arch Ophthalmol 1995;113:62-69.
18. Olivier S, Chow DR, Packo KH, MacCumber MW, Awh CC. Subretinal recombinant tissue plasminogen activator injection and pneumatic displacement of thick submacular hemorrhage in age-related macular degeneration. Ophthalmology 2004;111:1201-1208.
19. Eyetech Study Group. Anti-vascular endothelial growth factor therapy for subfoveal choroidal neovascularization secondary to age-related macular degeneration: phase II study results. Ophthalmology 2003;110:979-986.
20. Evangelos SG, Anthony PA, Emmett TC Jr, Matthew F, David RG. Pegaptanib for neovascular age-related macular degeneration. N Engl J Med 2004;351:2805-2817.
21. de Juan EJ, Machemer R. Vitreous surgery for hemorrhagic and fibrous complications of age-related macular degeneration. Am J Ophthalmol 1988;105:25-29.
22. Vander JF. Tissue plasminogen activator irrigation to facilitate removal of subretinal hemorrhage during vitrectomy. Ophthalmic Surg 1992;23:361-363.
23. Lewis H. Intraoperative fibrinolysis of submacular hemorrhage with tissue plasminogen activator and surgical drainage. Am J Ophthalmol 1994;118:559-568.
24. Lim JI, Drews-Botsch C, Sternberg P Jr, Capone A Jr, Aaberg TM Sr. Submacular hemorrhage removal. Ophthalmology 1995;102:1393-1399.
25. Hesse L, Meitinger D, Schmidt J. Little effect of tissue plasminogen activator in subretinal surgery for acute hemorrhage in age-related macular degeneration. Ger J Ophthalmol 1996;5:479-483.
26. Heriot W. Intravitreal gas and tPA: an outpatient procedure for subretinal haemorrhage. In: Vail Vitrectomy Meeting; 1996; Vail, CO.
27. Kimura AE, Reddy CV, Folk JC, Farmer SG. Removal of subretinal hemorrhage facilitated by preoperative intravitreal tissue plasminogen activator. Retina 1994;14:83-84.
28. Benner J, Morse L, Toth C, Landers MR, Hjelmeland L. Evaluation of a commercial recombinant tissue-type plasminogen activator preparation in the subretinal space of the cat. Arch Ophthalmol 1991;109:1731-1736.
29. Berrocal MH, Lewis ML, Flynn HW Jr. Variations in the clinical course of submacular hemorrhage. Am J Ophthalmol 1996;122:486-493.
30. Scupola A, Coscas G, Soubrane G, Balestrazzi E. Natural history of macular subretinal hemorrhage in age-related macular degeneration. Ophthalmologica 1999;213:97-102.
31. Schulze SD, Hesse L. Tissue plasminogen activator plus gas injection in patients with subretinal hemorrhage caused by age-related macular degeneration: predictive variables for visual outcome. Graefes Arch Clin Exp Ophthalmol 2002;240:717-720.
32. Callis K, Cullinane A, Horne M. Bioactivity of cryopreserved alteplase solutions. Am J Health System Pharmacy 1999;56:2056-2057.
33. Gehrs KM, Heriot WJ, de Juan E Jr. Transmission electron microscopic study of a subretinal choroidal neovascular membrane due to age-related macular degeneration. Arch Ophthalmol 1992;110:833-837.
34. Marmor M, Negi A, Maurice D. Kinetics of macromolecules injected into the subretinal space. Exp Eye Res 1985;40:687-696.
35. Takeuchi A, Kricorian G, Yao X, Kenny J, Marmor M. The rate and source of albumin entry into saline filled experimental retinal detachment. Invest Ophthalmol Vis Sci 1994;35:3792-3798.
36. Kwan S, Vijayasekaran S, McAllister I, Yu P, Yu D. A study of retinal penetration of intravitreal tenecteplase in pigs. Invest Ophthalmol Vis Sci. 2006 (in press).
37. Chen SN, Yang TC, Ho CL, et al. Retinal toxicity of intravitreal tissue plasminogen activator: case report and literature review. Ophthalmology 2003;110:704-708.
38. Handwerger BA, Blodi BA, Chandra SR, Olsen TW, Stevens TS. Treatment of submacular hemorrhage with low-dose intravitreal tissue plasminogen activator injection and pneumatic displacement [see comment]. Arch Ophthalmol 2001;119:28-32.
39. Ohji M, Saito Y, Hayashi A, Lewis JM, Tano Y. Pneumatic displacement of subretinal hemorrhage without tissue plasminogen activator. Arch Ophthalmol 1998;116:1326-1332.
40. Kamei M, Tano Y, Maeno T, et al. Surgical removal of submacular hemorrhage using tissue plasminogen activator and perfluorocarbon liquid. Am J Ophthalmol 1996;121:267-275.